WORLD JOURNAL OF ADVANCE
HEALTHCARE RESEARCH

Nadia Mohammed Saeed Nayeef*, Ali S. Mahmood, Abdul Sattar Sami Ibrahem and Shatha K. Atrah

ABSTRACT

Background: Menopausal women might have vulvovaginal atrophy, which is caused by hormonal changes.Women of various ages might develop vulvovaginal laxity and mucosal atrophy. This condition lowers lifequality. Vulvovaginal atrophy symptoms in women are now treated using fractional CO2 laser (10600nm).Objectives: The study examined fractional CO2 laser (10600nm) effectiveness for vulvovaginal atrophy andvaginal rejuvenation. Method: From July 2019 until the end of September 2019, this research was conducted atthe Institute of Laser's postgraduate research clinics for laser medicine. Twelve females, ranging in age from 42 to56 years, were enlisted in this study with symptoms of vulvovaginal atrophy. Point 28 at a distance of 1.0 mm,CO2 laser wavelength 10600 nm, 30 watts of power, 1.7 milliseconds of duration, scan mode normal, scan timesfourth, and scan rows five were the laser parameters utilized. Results: Seventy-five percent (n.9) of the twelvewomen who participated in the study were content with their treatment following two CO2 laser sessionsseparated by four weeks. Conclusion: Fractional CO2 laser therapy is a successful technique that produces feweradverse effects.